• Expanded microporous polytetrafluoroethylene (PTFE) has been used experimentally and clinically for small-vessel bypass or replacement grafting; the results vary widely. This study assessed short (4-cm) femoral and carotid artery replacement PTFE grafts and longer (12-cm) femoral artery bypass PTFE grafts that crossed a flexion crease. Pore size at the blood-graft interface ranged from 10 to 30 μ. At the end of three months, overall patency rate was 22%. No long bypass grafts remained patent. The pore size and type of anastomosis did not affect patency. The occlusion was always thrombotic, associated with fibrin at the suture line. Nine of 20 short carotid grafts (45%) and five of 22 short femoral grafts (22%) remained patent. These poor results indicate that further experimental studies are needed before PTFE is used clinically when an alternative exists.
(Arch Surg 113:863-866, 1978)
Walley BD, James PM, Meredith JH, Todd SK, Ogburn N. Expanded Microporous Polytetrafluoroethylene as Canine Arterial Bypass or Replacement Graft. Arch Surg. 1978;113(7):863–866. doi:10.1001/archsurg.1978.01370190085015
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: